Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Xeplion

Xeplion 25 mg prolonged release suspension for injection Xeplion 50 mg prolonged release suspension for injection Xeplion 75 mg prolonged release suspension for injection Xeplion 100 mg prolonged release suspension for injection Xeplion 150 mg prolonged release suspension for injection · Abschnitt 4.8 · PDF-Seite 11

HOS-124251 · Präparat HOS-095825

System Organ Adverse reactions Class Frequency Very Common Uncommon Rare Not knowna common Infections and upper respiratory pneumonia, bronchitis, eye infection, infestations tract infection, respiratory tract acarodermatitis urinary tract infection, sinusitis, infection, influenza cystitis, ear infection, tonsillitis, onychomycosis, cellulitis, subcutaneous abscess Blood and white blood cell count neutropenia, agranulocytosis lymphatic system decreased, anaemia thrombocytopenia, disorders eosinophil count increased Immune system hypersensitivity anaphylactic disorders reaction Endocrine hyperprolactinaemiab inappropriate disorders antidiuretic hormone secretion, glucose urine present Metabolism and hyperglycaemia, diabetes mellitusd, diabetic water intoxication nutrition weight increased, hyperinsulinaemia, ketoacidosis, disorders weight decreased, increased appetite, hypoglycaemia, decreased appetite anorexia, blood polydipsia triglycerides increased, blood cholesterol increased Psychiatric insomniae agitation, depression, sleep disorder, mania, catatonia, sleep-related disorders anxiety libido decreased, confusional state, eating disorder nervousness, somnambulism, nightmare blunted affect, anorgasmia

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.